nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylic acid—PTGS2—osteoarthritis	0.977	1	CbGaD
Salicylic acid—Acetylsalicylic acid—HSPA5—osteoarthritis	0.0092	0.495	CrCbGaD
Salicylic acid—Salicylate-sodium—PTGS2—osteoarthritis	0.0017	0.0916	CrCbGaD
Salicylic acid—Magnesium salicylate—PTGS2—osteoarthritis	0.00117	0.0628	CrCbGaD
Salicylic acid—Aminosalicylic Acid—PTGS2—osteoarthritis	0.0011	0.059	CrCbGaD
Salicylic acid—Diflunisal—PTGS2—osteoarthritis	0.0011	0.059	CrCbGaD
Salicylic acid—Salsalate—PTGS2—osteoarthritis	0.000992	0.0534	CrCbGaD
Salicylic acid—Meclofenamic acid—PTGS2—osteoarthritis	0.000978	0.0526	CrCbGaD
Salicylic acid—Mesalazine—PTGS2—osteoarthritis	0.000861	0.0463	CrCbGaD
Salicylic acid—Mefenamic acid—PTGS2—osteoarthritis	0.00076	0.0409	CrCbGaD
Salicylic acid—Acetylsalicylic acid—PTGS2—osteoarthritis	0.000741	0.0399	CrCbGaD
Salicylic acid—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.000363	0.0807	CbGpPWpGaD
Salicylic acid—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.000289	0.0641	CbGpPWpGaD
Salicylic acid—PTGS1—Eicosanoid Synthesis—PTGES—osteoarthritis	0.000236	0.0524	CbGpPWpGaD
Salicylic acid—PTGS2—Eicosanoid Synthesis—PTGES—osteoarthritis	0.000187	0.0416	CbGpPWpGaD
Salicylic acid—PTGS1—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000131	0.0292	CbGpPWpGaD
Salicylic acid—SLC16A1—Basigin interactions—MMP1—osteoarthritis	0.000129	0.0286	CbGpPWpGaD
Salicylic acid—AKR1C1—Metapathway biotransformation—GSTO1—osteoarthritis	0.000116	0.0257	CbGpPWpGaD
Salicylic acid—PTGS2—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000104	0.0231	CbGpPWpGaD
Salicylic acid—PTGS1—Overview of nanoparticle effects—CRP—osteoarthritis	8.33e-05	0.0185	CbGpPWpGaD
Salicylic acid—PTGS1—Overview of nanoparticle effects—FN1—osteoarthritis	7.69e-05	0.0171	CbGpPWpGaD
Salicylic acid—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—osteoarthritis	7.67e-05	0.017	CbGpPWpGaD
Salicylic acid—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—osteoarthritis	7.13e-05	0.0158	CbGpPWpGaD
Salicylic acid—CYP2C9—Arachidonic acid metabolism—PTGES—osteoarthritis	6.9e-05	0.0153	CbGpPWpGaD
Salicylic acid—PTGS2—Overview of nanoparticle effects—CRP—osteoarthritis	6.61e-05	0.0147	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—SOX9—osteoarthritis	6.43e-05	0.0143	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	6.41e-05	0.0142	CbGpPWpGaD
Salicylic acid—PTGS2—Overview of nanoparticle effects—FN1—osteoarthritis	6.1e-05	0.0136	CbGpPWpGaD
Salicylic acid—PTGS1—Overview of nanoparticle effects—PTGS2—osteoarthritis	5.59e-05	0.0124	CbGpPWpGaD
Salicylic acid—PTGS1—Overview of nanoparticle effects—CXCL8—osteoarthritis	5.42e-05	0.012	CbGpPWpGaD
Salicylic acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—osteoarthritis	4.71e-05	0.0105	CbGpPWpGaD
Salicylic acid—PTGS1—Eicosanoid Synthesis—PTGS2—osteoarthritis	4.63e-05	0.0103	CbGpPWpGaD
Salicylic acid—PTGS2—Overview of nanoparticle effects—CXCL8—osteoarthritis	4.3e-05	0.00955	CbGpPWpGaD
Salicylic acid—SLC16A1—Cell surface interactions at the vascular wall—MMP1—osteoarthritis	4.28e-05	0.00951	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—FMOD—osteoarthritis	4.18e-05	0.00928	CbGpPWpGaD
Salicylic acid—SLC16A1—Cell surface interactions at the vascular wall—FN1—osteoarthritis	3.91e-05	0.00868	CbGpPWpGaD
Salicylic acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—osteoarthritis	3.88e-05	0.00861	CbGpPWpGaD
Salicylic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoarthritis	3.79e-05	0.00841	CbGpPWpGaD
Salicylic acid—PTGS1—Overview of nanoparticle effects—TNF—osteoarthritis	3.77e-05	0.00837	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—IHH—osteoarthritis	3.72e-05	0.00827	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—FMOD—osteoarthritis	3.5e-05	0.00777	CbGpPWpGaD
Salicylic acid—PTGS1—Biological oxidations—GSTO1—osteoarthritis	3.44e-05	0.00764	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—COL2A1—osteoarthritis	3.41e-05	0.00757	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	3.05e-05	0.00676	CbGpPWpGaD
Salicylic acid—PTGS1—Overview of nanoparticle effects—IL6—osteoarthritis	3.04e-05	0.00676	CbGpPWpGaD
Salicylic acid—PTGS2—Overview of nanoparticle effects—TNF—osteoarthritis	2.99e-05	0.00665	CbGpPWpGaD
Salicylic acid—ALB—Platelet degranulation—HSPA5—osteoarthritis	2.89e-05	0.00642	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PTGES—osteoarthritis	2.85e-05	0.00634	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—TGFBI—osteoarthritis	2.78e-05	0.00617	CbGpPWpGaD
Salicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—HSPA5—osteoarthritis	2.76e-05	0.00612	CbGpPWpGaD
Salicylic acid—ALB—Platelet degranulation—TIMP1—osteoarthritis	2.76e-05	0.00612	CbGpPWpGaD
Salicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—TIMP1—osteoarthritis	2.62e-05	0.00583	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IHH—osteoarthritis	2.61e-05	0.00579	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MCF2L—osteoarthritis	2.61e-05	0.00579	CbGpPWpGaD
Salicylic acid—PTGS1—Arachidonic acid metabolism—PTGS2—osteoarthritis	2.58e-05	0.00572	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—CRP—osteoarthritis	2.44e-05	0.00543	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—CRP—osteoarthritis	2.43e-05	0.00539	CbGpPWpGaD
Salicylic acid—PTGS2—Overview of nanoparticle effects—IL6—osteoarthritis	2.42e-05	0.00536	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—GSTO1—osteoarthritis	2.4e-05	0.00533	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—BGN—osteoarthritis	2.32e-05	0.00516	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—GSTO1—osteoarthritis	2.01e-05	0.00446	CbGpPWpGaD
Salicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—osteoarthritis	1.98e-05	0.0044	CbGpPWpGaD
Salicylic acid—ABCB1—HIF-1-alpha transcription factor network—SMAD3—osteoarthritis	1.98e-05	0.0044	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—CRP—osteoarthritis	1.98e-05	0.00439	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—HSPA5—osteoarthritis	1.96e-05	0.00435	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—FMOD—osteoarthritis	1.95e-05	0.00433	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—BGN—osteoarthritis	1.95e-05	0.00432	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—CRP—osteoarthritis	1.94e-05	0.00431	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—COL9A2—osteoarthritis	1.91e-05	0.00425	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	1.88e-05	0.00417	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—TIMP1—osteoarthritis	1.87e-05	0.00415	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—COL9A1—osteoarthritis	1.86e-05	0.00413	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IL1A—osteoarthritis	1.84e-05	0.00408	CbGpPWpGaD
Salicylic acid—CYP2C9—Biological oxidations—GSTO1—osteoarthritis	1.81e-05	0.00402	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL1A—osteoarthritis	1.79e-05	0.00398	CbGpPWpGaD
Salicylic acid—CYP2C9—Metapathway biotransformation—GSTO1—osteoarthritis	1.78e-05	0.00396	CbGpPWpGaD
Salicylic acid—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoarthritis	1.69e-05	0.00376	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—PTGS2—osteoarthritis	1.64e-05	0.00364	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PTGES—osteoarthritis	1.59e-05	0.00353	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—CRP—osteoarthritis	1.57e-05	0.00348	CbGpPWpGaD
Salicylic acid—ALB—Platelet degranulation—FN1—osteoarthritis	1.56e-05	0.00347	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—IL1B—osteoarthritis	1.52e-05	0.00339	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—IL1B—osteoarthritis	1.51e-05	0.00336	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—LEP—osteoarthritis	1.5e-05	0.00333	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	1.49e-05	0.00331	CbGpPWpGaD
Salicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—FN1—osteoarthritis	1.49e-05	0.00331	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	1.48e-05	0.00328	CbGpPWpGaD
Salicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoarthritis	1.38e-05	0.00306	CbGpPWpGaD
Salicylic acid—ALB—Platelet degranulation—IGF1—osteoarthritis	1.37e-05	0.00304	CbGpPWpGaD
Salicylic acid—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	1.35e-05	0.00301	CbGpPWpGaD
Salicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoarthritis	1.3e-05	0.0029	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	1.28e-05	0.00285	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—BMP2—osteoarthritis	1.27e-05	0.00283	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.26e-05	0.00279	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—IL1B—osteoarthritis	1.23e-05	0.00274	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	1.22e-05	0.00271	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—IL1B—osteoarthritis	1.21e-05	0.00269	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	1.21e-05	0.00268	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—MMP1—osteoarthritis	1.16e-05	0.00258	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—SMAD3—osteoarthritis	1.14e-05	0.00253	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—GSTO1—osteoarthritis	1.12e-05	0.00249	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—TNF—osteoarthritis	1.11e-05	0.00246	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—TNF—osteoarthritis	1.1e-05	0.00244	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—BGN—osteoarthritis	1.09e-05	0.00241	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—FN1—osteoarthritis	1.06e-05	0.00235	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—PTGS2—osteoarthritis	1.05e-05	0.00234	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—FMOD—osteoarthritis	1.03e-05	0.00228	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—CXCL8—osteoarthritis	9.98e-06	0.00222	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	9.86e-06	0.00219	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—IL1B—osteoarthritis	9.79e-06	0.00217	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	9.75e-06	0.00217	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—CXCL8—osteoarthritis	9.75e-06	0.00216	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—FMOD—osteoarthritis	9.72e-06	0.00216	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IL1B—osteoarthritis	9.57e-06	0.00213	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL1B—osteoarthritis	9.35e-06	0.00208	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—IGF1—osteoarthritis	9.28e-06	0.00206	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—MMP9—osteoarthritis	9.02e-06	0.002	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—TNF—osteoarthritis	8.94e-06	0.00199	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—IL6—osteoarthritis	8.93e-06	0.00198	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—IL6—osteoarthritis	8.87e-06	0.00197	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MMP3—osteoarthritis	8.83e-06	0.00196	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—TNF—osteoarthritis	8.78e-06	0.00195	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IHH—osteoarthritis	8.66e-06	0.00192	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	8.44e-06	0.00187	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PTGES—osteoarthritis	8.36e-06	0.00186	CbGpPWpGaD
Salicylic acid—ALB—Platelet degranulation—TGFB1—osteoarthritis	8.21e-06	0.00182	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—FMOD—osteoarthritis	8.14e-06	0.00181	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—SMAD3—osteoarthritis	7.99e-06	0.00177	CbGpPWpGaD
Salicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoarthritis	7.82e-06	0.00174	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—TGFB1—osteoarthritis	7.44e-06	0.00165	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—TGFB1—osteoarthritis	7.27e-06	0.00161	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—IL6—osteoarthritis	7.22e-06	0.0016	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—TNF—osteoarthritis	7.1e-06	0.00158	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—IL6—osteoarthritis	7.09e-06	0.00157	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—TNF—osteoarthritis	6.94e-06	0.00154	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—FN1—osteoarthritis	6.93e-06	0.00154	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	6.91e-06	0.00153	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—LEP—osteoarthritis	6.83e-06	0.00152	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—TNF—osteoarthritis	6.79e-06	0.00151	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—PTGS2—osteoarthritis	6.68e-06	0.00148	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PTGES—osteoarthritis	6.63e-06	0.00147	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—HSPA5—osteoarthritis	6.61e-06	0.00147	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—FMOD—osteoarthritis	6.58e-06	0.00146	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—ESR1—osteoarthritis	6.52e-06	0.00145	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TGFBI—osteoarthritis	6.46e-06	0.00143	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—FN1—osteoarthritis	6.44e-06	0.00143	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TIMP1—osteoarthritis	6.3e-06	0.0014	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	6.08e-06	0.00135	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	5.98e-06	0.00133	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GSTO1—osteoarthritis	5.89e-06	0.00131	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—FMOD—osteoarthritis	5.77e-06	0.00128	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—IL6—osteoarthritis	5.73e-06	0.00127	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—BGN—osteoarthritis	5.7e-06	0.00127	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IGF1—osteoarthritis	5.64e-06	0.00125	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IL6—osteoarthritis	5.6e-06	0.00124	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PTGS2—osteoarthritis	5.6e-06	0.00124	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—GSTO1—osteoarthritis	5.58e-06	0.00124	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—TGFB1—osteoarthritis	5.56e-06	0.00124	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—BGN—osteoarthritis	5.4e-06	0.0012	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—FMOD—osteoarthritis	5.39e-06	0.0012	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTGES—osteoarthritis	5.37e-06	0.00119	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	5.06e-06	0.00112	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	4.96e-06	0.0011	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—TGFB1—osteoarthritis	4.83e-06	0.00107	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	4.72e-06	0.00105	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTGES—osteoarthritis	4.7e-06	0.00104	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GSTO1—osteoarthritis	4.67e-06	0.00104	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CXCL8—osteoarthritis	4.54e-06	0.00101	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—BGN—osteoarthritis	4.53e-06	0.00101	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTGES—osteoarthritis	4.39e-06	0.000975	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MMP9—osteoarthritis	4.11e-06	0.000912	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—MMP1—osteoarthritis	3.92e-06	0.00087	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTO1—osteoarthritis	3.78e-06	0.00084	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	3.68e-06	0.000817	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—BGN—osteoarthritis	3.66e-06	0.000813	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	3.64e-06	0.000809	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—IL6—osteoarthritis	3.64e-06	0.000808	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	3.59e-06	0.000796	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—FN1—osteoarthritis	3.57e-06	0.000794	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TGFB1—osteoarthritis	3.38e-06	0.000751	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	3.35e-06	0.000744	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTO1—osteoarthritis	3.31e-06	0.000736	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—BGN—osteoarthritis	3.21e-06	0.000712	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IGF1—osteoarthritis	3.13e-06	0.000695	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PTGS2—osteoarthritis	3.12e-06	0.000693	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTO1—osteoarthritis	3.09e-06	0.000687	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—BGN—osteoarthritis	3e-06	0.000666	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—SMAD3—osteoarthritis	2.65e-06	0.000589	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL6—osteoarthritis	2.55e-06	0.000566	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	2.36e-06	0.000525	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.94e-06	0.00043	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TGFB1—osteoarthritis	1.88e-06	0.000417	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PTGS2—osteoarthritis	1.64e-06	0.000364	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TGFB1—osteoarthritis	1.12e-06	0.000249	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTGS2—osteoarthritis	1.05e-06	0.000234	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTGS2—osteoarthritis	9.22e-07	0.000205	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTGS2—osteoarthritis	8.62e-07	0.000191	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IL6—osteoarthritis	8.47e-07	0.000188	CbGpPWpGaD
